Previous Close | 2.5900 |
Open | 2.3500 |
Bid | 2.2000 |
Ask | 2.3500 |
Strike | 7.50 |
Expire Date | 2024-05-17 |
Day's Range | 2.0500 - 2.4500 |
Contract Range | N/A |
Volume | |
Open Interest | 62 |
PETACH TIKVA, Israel, May 20, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended March 31, 2024, before market open on Tuesday, May 28, 2024. Erez Meltzer, Chief Executive Officer, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Inte
Company earns Gold Seal of Approval® for Ambulatory Health Care Accreditation PETACH TIKVA, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that its wholly-owned subsidiary, USARAD Holdings, Inc., a leading provider of teleradiology services, has earned The Joint Commission’s Gold Seal of Approval® for Ambulatory Health Care Accreditation for the sixth time by demonstrating con
PETACH TIKVA, Israel, May 07, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announces that Company management will participate in three investor conferences in the month of May 2024: EF Hutton 2024 Annual Global ConferenceAGP 2024 Healthcare ConferenceBenchmark 2024 Healthcare House Call Virtual Conference About EF Hutton 2024 Annual Global Conference Nanox’s Chief Executive Officer, Erez Meltzer, and